ProGrow Pharma Partners

2018
Introduction
• ProGrow Pharma (PGP) Partners, established in 2017, is an advisory firm with a
team of professionals having more than a decade of experience in serving the
Pharmaceutical Industry. Our exclusive focus and knowledge of the Global Biotech,
and Healthcare sector enables us to offer advisory services to healthcare companies
(Market leaders, Innovators, Generic Players CROs, and others) and its Investors
(Private Equity investors, Venture Capitalists, HNIs, and others).
• Our dedicated team based in Vadodara, Mumbai, and Bangalore (India) brings together
scientific expertise, financial know-how, and industry experience to understand the
science and challenges associated with innovation, drug development, clinical trials,
patents & litigations, and competition across geographies.

Domain Knowledge and Serving Diversified Pharma Clients set us Apart

2
Foundation of ProGrow Pharma Partners
Experienced professionals working at MP Advisors/ Mehta Partners have started
their independent venture. This decision was based on the spirit of independent
thinking and entrepreneurship while working under the umbrella of MP Advisors,
which bestowed them with the confidence to execute projects, interact with
clients, and deliver in a timely manner.

3
Our Services
Our Team’s understanding of the Global healthcare industry and networking with
industry professionals and management helps us to identify opportunities and
advise on judicious investment allocation.
Our services:
• Strategic Advisory Services
• Financial Services
• Customized Research and Analysis
• Turnkey Projects for a Pharma Venture in collaboration with our Partner

Serving the Full Spectrum of Pharma Companies and Decision Makers in

Pharma Investment
4
Strategic Advisory Services
• Strategic Partnership, Joint Ventures, and Tie-ups – We mediate JV/Collaborations by
identifying products/companies/facilities in different geographies that align with a client’s
business.
• Investment and Divestment – Helping to find right candidate for mergers and
acquisitions – Our team can assist in brand acquisition/divestment, total or partial sale of
manufacturing facility etc. to create long term value for the business.
• Aligning Portfolio Strategy to Company’s Values and Growth – Provide a holistic
perspective of the dynamic business environment. We assist our clients to identify new
focus area, formulate strategies to hedge risk of dependence on single or few products,
impact of patent Expiry, and so on.

5
Strategic Advisory Services contd…
• Licensing – With our update knowledge of Pharma companies across the Globe, our team
identifies In-licensing/ Out-licensing opportunities of innovative drugs in the pipeline
(Small molecules/ Biologics) suitable to our client’s need.
• Understanding Complex Regulatory Environment in Different Geographies – The
Team provides critical information and timely input to clients on the regulatory front.
With the changing regulations and government’s initiations/ policies, we assist our clients
in smooth execution of projects in a given geography.
• Techno-Commercial Feasibility Studies in Different Geographies – The team of PGP
Partners offers this service under Spectrum ProGrow Advisors Pvt. Ltd. /SPGA in
which it provides expert’s perspective, analysis and support on creating a new, scalable
organisation structure to ensure strategic alignment, efficient Regional engagement, and
productivity..
6
Financial Services
With domain knowledge – Technical and Financial under one platform, we use
appropriate valuation methodology to assist clients in their investment decision.
• Fund raising through private equity, venture capital, HNI etc for Start ups and Mature
Businesses
• Investment opportunity assessment of sub sectors, API, formulations
• Assist investment banks in identifying opportunities in Pharma and co execute the projects
• Third party financial due diligence
• Market models of launched products to assess commercial potential of NCE / NBE/ NME/
Generics in a disease
• Business evaluation of start-up pharma companies

Transforming Business Challenges into Growth Opportunities

7
Customized Research and Analysis
Innovation demands an in-depth understanding of the Problem in order to arrive at a solution
or strategy. Team’s expertise and in-depth analysis of the technologies, competition, unmet
need, financial risks and opportunities provide holistic perspective. We provide –
• In depth Analysis of specific Therapeutic areas/ Disease/ Drug/Targets
• Technology Platforms assessment amidst evolving science and competition.
• Target and mechanism of action of drugs along with the clinical data and side effect
• In depth Reports of Specific Companies/Sector/Geographies
• Market analysis of innovative/Generic Drugs before and post patent expiry in various geographies.
Analysis of competition after Patent expiry and litigations to identify potential opportunities/risk.
• Market model for leading drugs amidst the competitive landscape, patent expiry and dynamic healthcare
reforms

Knowledge/ Insights to Expand and Grow your Business /Investment

8
Services through our JV
Spectrum ProGrow Advisors Pvt. Ltd. (SPGA) is a JV between Spectrum
Designers & Project Engineers Pvt. Ltd. (SDPE) & members of ProGrow Pharma
Partners.

SPGA deploys the specific expertise of the members to provide services from
conceptualization of a project idea to Commercialization of products in any
geography.

End-to-End innovative and efficient solutions for the Pharma and/or Para-
pharma Industries

9
SPGA – Turnkey Projects

Concept Design, Basic &

Pre-Feasibility & Techno-
Comprehensive Market Detailed Engineering,
Commercial Feasibility
Study Procurement assistance,
Study
Project Management

Regulatory Compliance Documentation –

Audit, Training & Support – Strategic Validation & Qualification,
Courses services, Advisory services, SOPs, QMS, Tech Transfer,
and Technical services etc.

Offered by Spectrum Offered by Spectrum

ProGrow Advisors Pvt Ltd PharmaTECH Consultants Pvt Ltd

10
Select Ongoing Projects
• Strategic Advisory to the India pharma company – In-Licensing of NCE/ NME
molecule for Domestic Market
• Identify buyers or strategic investor/ partner for existing injectable facility, Biotech
start-up, multi-specialty hospitals, etc.
• Valuation of Biotech Company – Evaluate the pipeline, Technology platform and its
IP assets
• Market Feasibility study of African countries for our overseas client – Kenya,
Ethiopia, Uganda, North Sudan, Democratic Republic of Congo
• Techno-Commercial Feasibility Study to set up an Active Pharmaceutical Ingredient
(API) manufacturing facility for Domestic Supplies

11
Select Projects Executed by Our Team Members
• Third party and/or Independent Business and Technical Due Diligence and/or Valuation of
companies, such as, CRO, Nutraceutical companies, API & Finished Dosage manufacturer,
Preclinical CROs, Vaccine, etc.
• Techno-Commercial Feasibility Study to put up a Finished Dosage Manufacturing plant in new
geographies. In-depth analysis of Local pharma market and Regional exports, as well for Semi-
Regulated markets like Sri Lanka, Ethiopia, etc.
• Evaluation of Business Plan and Marketing Strategy of a New Venture (international
subsidiary) of India Pharma Company
• Global Market Assessment and In-Licensing & Out-licensing of NCE, NME, NDDS products
• Product pipeline assessment, prioritized preclinical NCE/value-added developmental products,
identifying opportunities in niche therapy area, market potential of products in light of
competitions for renowned CRAMS company

12
Leading Team
Dr Subita Srimal, PhD, (Biochemistry), lends the flavour of a scientist, researcher, entrepreneur and Pharma
advisor to the company. Her 25+ years of experience in the understanding of innovative drugs/ technologies being
developed by companies across the globe, is useful to identify new opportunities for companies. Her experience
while consulting included in-depth analysis of global innovative biotech companies, Technical and strategic
advisory services to Pharma companies.
Sanjeev Mishra, B.Sc., MBA, has 12+ years of experience; A finance professional and chemistry background has
an in depth understanding of the complex steps of drug development along with their risks and rewards. His
acquired understanding of drugs and diseases helped him author/ Co-author detailed therapy class/specific diseases
reports. Sanjeev’s multitasking ability and experience provides valuable financial and technical input required in
evaluating biotech/ pharma companies.

Khyati Thakrar, MS (Microbiology), PGDBM, 12+ years of experience, offers a blend of science and financial
expertise besides her acquired IT skills. Khyati possess an in depth understanding of science, drug targets and
their mechanism of action. Developing market models of drugs in a competitive scenario, understanding the
diversified business of Pharma and Biotech companies across the Globe and valuing their future potential are some
of her prized attributes.
Bhavita Nagrani is a Chartered Financial Analyst (CFA) from ICFAI with 8+ years of experience as Pharma
Research Analyst. Bhavita has a comprehensive understanding of the Pharma companies, drug portfolio
specifically Indian and the secrets behind their growth or stagnation/risk reward. Through her understanding of
drug patent litigations, she is skilled in identifying opportunities for generics and impact on innovator companies.

13
Other Team Members
• Dr Priya Jishnu, Ph.D (Microbiology, MS. University Baroda) has served the pharma industry and academia for over
12+ years. Her understanding of the regulatory process, documentation and basic science is a valuable attribute.
Practical Insights gained from hands on experience while addressing complex problems in research will be useful in
analysis of innovative products being developed WW. Industry exposure at A. V. Thomas -McCormick Ltd equipped
her with the process of documentation, ISO certifications, and HACCP audits lab setting up etc. She is well
networked with premier research organizations like M S Swaminathan Research foundation, Chennai; SPIC Science
Foundation, Chennai; NCL Pune, Genome Research Centre of M S University.
• Gauri Sanghavi, M.Sc. (Biochemistry), Govt. of India certified Patent agent, has 7 years of technical experience. She
is competent in pharma portfolio management and customized research and analysis. Her expertise include Pipeline
Analysis, identifying late-stage drug candidates suitable for regulatory approvals, analyzing drug clinical data, etc.
• Nupur Varia, M. Pharm (Quality Assurance) has 3+ years of experience in the Pharmaceutical Industry verticals –
Pharma Advisory services, Quality Control and Quality Assurance. She utilizes her skills and capabilities for adding
value to the company.
• Shivani Panchal, B. Pharm, Pharmaceutical MBA (Marketing) has 2 years of experience in the Product Planning &
Inventory Control and Pharma Advisory services. She also worked on various strategic and feasibility study projects.

14
Contact Us
We are accessible via-
pgp@pgppartners.com
+91 265 2253508; +91 74900 55873

C-227, Siddharth Excellence, Nr Shivashray Bungalows, Opp. Vasna D-

Mart, Vasna Road, Vadodara -390015
www.pgppartners.com

15